'PY4' |
'DPH' |
'Alameda Health System' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.2066' |
'' |
'63' |
'0' |
'326' |
'0' |
'0.1933' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.1583' |
'' |
'49' |
'0' |
'326' |
'0' |
'0.1503' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-CAC2' |
'Q-QPP118 ' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.9144' |
'' |
'371' |
'0' |
'406' |
'0' |
'0.9138' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.9199' |
'' |
'911' |
'0' |
'975' |
'0' |
'0.9344' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'622' |
'0' |
'637' |
'0' |
'0.9765' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-CAC5' |
'Q-CMS347' |
'Statin Therapy for the Prevention and Treatment of Cardiovascular Disease' |
'Reported' |
'' |
'' |
'0.7761' |
'' |
'3662' |
'0' |
'4761' |
'0' |
'0.7692' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'1952' |
'0' |
'3244' |
'0' |
'0.6017' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-IHE1' |
'Q-IHE1' |
'Childhood Immunization Status (CIS 10) - -Black/African American' |
'Reported' |
'' |
'' |
'0.3207' |
'' |
'27' |
'0' |
'91' |
'0' |
'0.2967' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-IHE2' |
'Q-IHE2' |
'Exclusive Breast Milk Feeding (PC-05) - -Asian' |
'Reported' |
'' |
'' |
'0.6436' |
'' |
'29' |
'0' |
'46' |
'0' |
'0.6304' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4544' |
'' |
'281' |
'0' |
'619' |
'0' |
'0.454' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.6834' |
'' |
'16683' |
'0' |
'24553' |
'0' |
'0.6795' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.7214' |
'' |
'14394' |
'0' |
'20513' |
'0' |
'0.7017' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Alameda Health System' |
'Q-PS5' |
'Q-SSI' |
'Surgical Site Infection (SSI)' |
'Reported' |
'' |
'' |
'0' |
'' |
'28' |
'0' |
'' |
'4' |
'' |
'4' |
'N/A' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'273' |
'0' |
'306' |
'0' |
'0.8922' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-IHE1' |
'Q-IHE1' |
'Exclusive Breast Milk Feeding (PC-05) - -Black/African American' |
'Reported' |
'' |
'' |
'0.5331' |
'' |
'33' |
'0' |
'65' |
'0' |
'0.5077' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Cesarean Birth (PC02-CH) - -Black/African American' |
'Reported' |
'' |
'' |
'0.2481' |
'' |
'36' |
'0' |
'140' |
'0' |
'0.2571' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.7133' |
'' |
'390' |
'0' |
'1207' |
'0' |
'0.3231' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Antelope Valley Hospital' |
'Q-PS1' |
'Q-STK-2' |
'Discharged on Antithrombotic Therapy' |
'Reported' |
'' |
'' |
'0.9959' |
'' |
'215' |
'0' |
'216' |
'0' |
'0.9954' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.6978' |
'' |
'51' |
'0' |
'235' |
'0' |
'0.217' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.7637' |
'' |
'85' |
'0' |
'235' |
'0' |
'0.3617' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.7587' |
'' |
'738' |
'0' |
'990' |
'0' |
'0.7455' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-CAD3' |
'Q-KED ' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'1262' |
'0' |
'2374' |
'0' |
'0.5316' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-CC1' |
'Q-TRC' |
'Transitions of Care (TRC)' |
'Reported' |
'' |
'' |
'0.78' |
'' |
'716' |
'0' |
'720' |
'0' |
'0.9944' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Immunizations for Adolescents - -Black/African American' |
'Reported' |
'' |
'' |
'0.309' |
'' |
'' |
'1' |
'33' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Child and Adolescent Well Care Visits - -Black/African American' |
'Reported' |
'' |
'' |
'0.4915' |
'' |
'316' |
'0' |
'662' |
'0' |
'0.4773' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.2933' |
'' |
'3752' |
'0' |
'15246' |
'0' |
'0.2461' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.8826' |
'' |
'13075' |
'0' |
'14844' |
'0' |
'0.8808' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-PC15' |
'Q-WCC' |
'BMI' |
'Reported' |
'' |
'' |
'0.7587' |
'' |
'3479' |
'0' |
'4663' |
'0' |
'0.7461' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Nutrition' |
'Reported' |
'' |
'' |
'0.6651' |
'' |
'3019' |
'0' |
'4663' |
'0' |
'0.6474' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Arrowhead Regional Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Physical Activity' |
'Reported' |
'' |
'' |
'0.6466' |
'' |
'2939' |
'0' |
'4663' |
'0' |
'0.6303' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Bear Valley Community Hospital' |
'Q-OA3' |
'Q-QPP415' |
'Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older' |
'Reported' |
'' |
'' |
'0.86' |
'' |
'64' |
'0' |
'75' |
'0' |
'0.8533' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Bear Valley Community Hospital' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5938' |
'' |
'940' |
'0' |
'1679' |
'0' |
'0.5599' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Bear Valley Community Hospital' |
'Q-PC16' |
'Q-W30' |
'15 Months-30 Months' |
'Reported' |
'' |
'' |
'0.6643' |
'' |
'18' |
'0' |
'52' |
'0' |
'0.3462' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Bear Valley Community Hospital' |
'Q-PC16' |
'Q-W30' |
'Well-Child Visits in the First 30 Months of Life (W30)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Bear Valley Community Hospital' |
'Q-PC16' |
'Q-W30' |
'First 15 Months' |
'Reported' |
'' |
'' |
'0.4499' |
'' |
'' |
'1' |
'67' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8621' |
'' |
'1038' |
'0' |
'1213' |
'0' |
'0.8557' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8925' |
'' |
'2428' |
'0' |
'2730' |
'0' |
'0.8894' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'654' |
'0' |
'736' |
'0' |
'0.8886' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'3762' |
'0' |
'6319' |
'0' |
'0.5953' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'468' |
'0' |
'870' |
'0' |
'0.5379' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'1143' |
'0' |
'1379' |
'0' |
'0.8289' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-PC10' |
'Q-LSC' |
'Lead Screening in Children' |
'Reported' |
'' |
'' |
'0.6131' |
'' |
'827' |
'0' |
'1454' |
'0' |
'0.5688' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5638' |
'' |
'22784' |
'0' |
'43547' |
'0' |
'0.5232' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.7182' |
'' |
'27113' |
'0' |
'31525' |
'0' |
'0.86' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Contra Costa Regional Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.8988' |
'' |
'27559' |
'0' |
'28288' |
'0' |
'0.9742' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Eastern Plumas Health Care' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'132' |
'0' |
'484' |
'0' |
'0.2727' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Eastern Plumas Health Care' |
'Q-PC14' |
'Q-CMS138' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Eastern Plumas Health Care' |
'Q-PC14' |
'Q-CMS138' |
'Rate 1 (informational only)' |
'Reported' |
'' |
'' |
'0' |
'' |
'506' |
'0' |
'536' |
'0' |
'0.944' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Eastern Plumas Health Care' |
'Q-PC14' |
'Q-CMS138' |
'Rate 2' |
'Reported' |
'' |
'' |
'0.7848' |
'' |
'107' |
'0' |
'139' |
'0' |
'0.7698' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Eastern Plumas Health Care' |
'Q-PC14' |
'Q-CMS138' |
'Rate 3' |
'Reported' |
'' |
'' |
'0.8911' |
'' |
'474' |
'0' |
'536' |
'0' |
'0.8843' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'El Camino Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'El Camino Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Exclusive Breast Milk Feeding (PC-05) - -Asian' |
'Reported' |
'' |
'' |
'0.4776' |
'' |
'' |
'1' |
'32' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'El Camino Hospital' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.2258' |
'' |
'' |
'1' |
'45' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'El Centro Regional Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.7637' |
'' |
'40' |
'0' |
'95' |
'0' |
'0.4211' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'El Centro Regional Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.7155' |
'' |
'2018' |
'0' |
'2917' |
'0' |
'0.6918' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'El Centro Regional Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.3176' |
'' |
'1034' |
'0' |
'3786' |
'0' |
'0.2731' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'El Centro Regional Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.8624' |
'' |
'3829' |
'0' |
'4461' |
'0' |
'0.8583' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'El Centro Regional Medical Center' |
'Q-PC3' |
'Q-WCV' |
'Child and Adolescent Well Care Visits' |
'Reported' |
'' |
'' |
'0.5384' |
'' |
'1009' |
'0' |
'1906' |
'0' |
'0.5294' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-MPH5' |
'Q-PPC-PRE' |
'Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE)' |
'Reported' |
'' |
'' |
'0.8864' |
'' |
'45' |
'0' |
'51' |
'0' |
'0.8824' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-PC9' |
'Q-IMA' |
'Immunizations for Adolescents' |
'Reported' |
'' |
'' |
'0.309' |
'' |
'16' |
'0' |
'58' |
'0' |
'0.2759' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-PS4' |
'Q-CDI' |
'Reduction in Hospital Acquired Clostridium Difficile Infections' |
'Reported' |
'' |
'' |
'0' |
'' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'49' |
'0' |
'144' |
'0' |
'0.3403' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Hazel Hawkins Memorial Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3636' |
'' |
'68' |
'0' |
'187' |
'0' |
'0.3636' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Jerold Phelps Community Hospital' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'105' |
'0' |
'271' |
'0' |
'0.3875' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Jerold Phelps Community Hospital' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'' |
'1' |
'236' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'John C Fremont Healthcare District' |
'Q-CAC1' |
'Q-CBP' |
'Controlling High Blood Pressure (CBP)' |
'Reported' |
'' |
'' |
'0.5061' |
'' |
'70' |
'0' |
'144' |
'0' |
'0.4861' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'John C Fremont Healthcare District' |
'Q-PC2' |
'Q-CCS' |
'Cervical Cancer Screening (CCS)' |
'Reported' |
'' |
'' |
'0.518' |
'' |
'151' |
'0' |
'585' |
'0' |
'0.2581' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.1075' |
'' |
'' |
'1' |
'47' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.157' |
'' |
'' |
'1' |
'47' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-CAC5' |
'Q-CMS347' |
'Statin Therapy for the Prevention and Treatment of Cardiovascular Disease' |
'Reported' |
'' |
'' |
'0.6667' |
'' |
'708' |
'0' |
'1100' |
'0' |
'0.6436' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.3096' |
'' |
'200' |
'0' |
'685' |
'0' |
'0.292' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-PC3' |
'Q-WCV' |
'Child and Adolescent Well Care Visits' |
'Reported' |
'' |
'' |
'0.6075' |
'' |
'3036' |
'0' |
'5009' |
'0' |
'0.6061' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Kaweah Delta Health Care District' |
'Q-PC9' |
'Q-IMA' |
'Immunizations for Adolescents' |
'Reported' |
'' |
'' |
'0.3816' |
'' |
'121' |
'0' |
'329' |
'0' |
'0.3678' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Remission or Response for Adolescents and Adults (DRR-E)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Remission (Adolescents) - informational only' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Response (Adolescents) - informational only' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Follow-Up PHQ-9 (Adolescents) - informational only' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'11' |
'0' |
'' |
'4' |
'' |
'4' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Remission (Adults)' |
'Reported' |
'' |
'' |
'0.0984' |
'' |
'29' |
'0' |
'314' |
'0' |
'0.0924' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Response (Adults)' |
'Reported' |
'' |
'' |
'0.1465' |
'' |
'42' |
'0' |
'314' |
'0' |
'0.1338' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Follow-Up PHQ-9 (Adults)' |
'Reported' |
'' |
'' |
'0.3851' |
'' |
'111' |
'0' |
'314' |
'0' |
'0.3535' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8855' |
'' |
'164' |
'0' |
'186' |
'0' |
'0.8817' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8937' |
'' |
'310' |
'0' |
'348' |
'0' |
'0.8908' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'68' |
'0' |
'69' |
'0' |
'0.9855' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'1225' |
'0' |
'2315' |
'0' |
'0.5292' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-CC2' |
'Q-PCR' |
'Plan All-Cause Readmissions (PCR)' |
'Reported' |
'' |
'' |
'0' |
'' |
'61' |
'0' |
'60.12' |
'0' |
'1.0146' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Controlling High Blood Pressure (CBP) - -Black/African American' |
'Reported' |
'' |
'' |
'0.5292' |
'' |
'149' |
'0' |
'290' |
'0' |
'0.5138' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Exclusive Breast Milk Feeding (PC-05) - -Black/African American' |
'Reported' |
'' |
'' |
'0.5152' |
'' |
'40' |
'0' |
'82' |
'0' |
'0.4878' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-OA1' |
'Q-URI ' |
'Appropriate Treatment for Upper Respiratory Infection (URI)' |
'Reported' |
'' |
'' |
'0.9434' |
'' |
'265' |
'0' |
'267' |
'0' |
'0.9925' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.7133' |
'' |
'137' |
'0' |
'198' |
'0' |
'0.6919' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5256' |
'' |
'7457' |
'0' |
'15510' |
'0' |
'0.4808' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6565' |
'' |
'5493' |
'0' |
'8725' |
'0' |
'0.6296' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Kern Medical Center' |
'Q-PS5' |
'Q-SSI' |
'Surgical Site Infection (SSI)' |
'Reported' |
'' |
'' |
'0' |
'' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Kern Valley Healthcare District' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'237' |
'0' |
'960' |
'0' |
'0.2469' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Kern Valley Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Kern Valley Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'' |
'1' |
'72' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Kern Valley Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'21' |
'0' |
'72' |
'0' |
'0.2917' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Kern Valley Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'22' |
'0' |
'72' |
'0' |
'0.3056' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.2687' |
'' |
'39' |
'0' |
'179' |
'0' |
'0.2179' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-MPH1' |
'Q-PC02' |
'Cesarean Birth (PC02-CH)' |
'Reported' |
'' |
'' |
'0.2481' |
'' |
'16' |
'0' |
'47' |
'0' |
'0.3404' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-MPH4' |
'Q-PPC-PST' |
'Prenatal and Postpartum Care: Postpartum Care (PPC-PST)' |
'Reported' |
'' |
'' |
'0.7111' |
'' |
'19' |
'0' |
'32' |
'0' |
'0.5938' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-MPH5' |
'Q-PPC-PRE' |
'Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE)' |
'Reported' |
'' |
'' |
'0.7932' |
'' |
'' |
'1' |
'32' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'896' |
'0' |
'3547' |
'0' |
'0.2526' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.2671' |
'' |
'671' |
'0' |
'3412' |
'0' |
'0.1967' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-PC4' |
'Q-CIS' |
'Childhood Immunization Status (CIS 10)' |
'Reported' |
'' |
'' |
'0.3187' |
'' |
'47' |
'0' |
'162' |
'0' |
'0.2901' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-PC7' |
'Q-DEV' |
'Developmental Screening in the First Three Years of Life' |
'Reported' |
'' |
'' |
'0.3665' |
'' |
'225' |
'0' |
'394' |
'0' |
'0.5711' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-PC8' |
'Q-CMS349' |
'HIV Screening Measure' |
'Reported' |
'' |
'' |
'0.2809' |
'' |
'338' |
'0' |
'1394' |
'0' |
'0.2425' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'28' |
'0' |
'87' |
'0' |
'0.3218' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Lompoc Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3427' |
'' |
'60' |
'0' |
'175' |
'0' |
'0.3429' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.2489' |
'' |
'105' |
'0' |
'437' |
'0' |
'0.2403' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.161' |
'' |
'67' |
'0' |
'437' |
'0' |
'0.1533' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-BH5' |
'Q-FUI' |
'30 Days' |
'Reported' |
'' |
'' |
'0.3894' |
'' |
'56' |
'0' |
'159' |
'0' |
'0.3522' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-BH5' |
'Q-FUI' |
'7 Days' |
'Reported' |
'' |
'' |
'0.2529' |
'' |
'36' |
'0' |
'159' |
'0' |
'0.2264' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-BH5' |
'Q-FUI' |
'Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.9199' |
'' |
'3826' |
'0' |
'4137' |
'0' |
'0.9248' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8971' |
'' |
'6649' |
'0' |
'7432' |
'0' |
'0.8946' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'3398' |
'0' |
'3564' |
'0' |
'0.9534' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'10248' |
'0' |
'17010' |
'0' |
'0.6025' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAR2' |
'Q-PCE' |
'Bronchodilator' |
'Reported' |
'' |
'' |
'0.7872' |
'' |
'68' |
'0' |
'91' |
'0' |
'0.7473' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAR2' |
'Q-PCE' |
'Pharmacotherapy Management of COPD Exacerbation (PCE)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-CAR2' |
'Q-PCE' |
'Systemic Corticosteroid' |
'Reported' |
'' |
'' |
'0.636' |
'' |
'51' |
'0' |
'91' |
'0' |
'0.5604' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Developmental Screening in the First Three Years of Life - -Black/African American' |
'Reported' |
'' |
'' |
'0.3112' |
'' |
'197' |
'0' |
'646' |
'0' |
'0.305' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-IHE2' |
'Q-IHE2' |
'Chlamydia Screening in Women (CHL) - -Asian' |
'Reported' |
'' |
'' |
'0.5599' |
'' |
'96' |
'0' |
'175' |
'0' |
'0.5486' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-MPH1' |
'Q-PC02' |
'Cesarean Birth (PC02-CH)' |
'Reported' |
'' |
'' |
'0.2481' |
'' |
'206' |
'0' |
'792' |
'0' |
'0.2601' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'1854' |
'0' |
'2199' |
'0' |
'0.8431' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Los Angeles County Health System' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.8988' |
'' |
'74182' |
'0' |
'80242' |
'0' |
'0.9245' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Mammoth Hospital' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5646' |
'' |
'337' |
'0' |
'643' |
'0' |
'0.5241' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Mammoth Hospital' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6928' |
'' |
'617' |
'0' |
'921' |
'0' |
'0.6699' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Mammoth Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Mammoth Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Mammoth Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'' |
'1' |
'45' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Mammoth Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'15' |
'0' |
'61' |
'0' |
'0.2459' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Marin General Hospital' |
'Q-MPH4' |
'Q-PPC-PST' |
'Prenatal and Postpartum Care: Postpartum Care (PPC-PST)' |
'Reported' |
'' |
'' |
'0.837' |
'' |
'201' |
'0' |
'224' |
'0' |
'0.8973' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Mayers Memorial Hospital District' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.7182' |
'' |
'73' |
'0' |
'90' |
'0' |
'0.8111' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Modoc Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.614' |
'' |
'538' |
'0' |
'924' |
'0' |
'0.5823' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-BH3' |
'Q-FUA ' |
'30 Days' |
'Reported' |
'' |
'' |
'0.1075' |
'' |
'' |
'1' |
'111' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-BH3' |
'Q-FUA ' |
'7 Days' |
'Reported' |
'' |
'' |
'0.071' |
'' |
'' |
'1' |
'111' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-BH3' |
'Q-FUA ' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.7968' |
'' |
'130' |
'0' |
'166' |
'0' |
'0.7831' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.7944' |
'' |
'224' |
'0' |
'287' |
'0' |
'0.7805' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8537' |
'' |
'40' |
'0' |
'47' |
'0' |
'0.8511' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.3971' |
'' |
'619' |
'0' |
'1590' |
'0' |
'0.3893' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'160' |
'0' |
'277' |
'0' |
'0.5776' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'243' |
'0' |
'263' |
'0' |
'0.924' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5394' |
'' |
'8898' |
'0' |
'17937' |
'0' |
'0.4961' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.5975' |
'' |
'15010' |
'0' |
'25697' |
'0' |
'0.5841' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6745' |
'' |
'14356' |
'0' |
'22100' |
'0' |
'0.6496' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC15' |
'Q-WCC' |
'BMI' |
'Reported' |
'' |
'' |
'0.8486' |
'' |
'9809' |
'0' |
'11594' |
'0' |
'0.846' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Nutrition' |
'Reported' |
'' |
'' |
'0.7832' |
'' |
'9027' |
'0' |
'11594' |
'0' |
'0.7786' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Physical Activity' |
'Reported' |
'' |
'' |
'0.7801' |
'' |
'9027' |
'0' |
'11594' |
'0' |
'0.7786' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3555' |
'' |
'15' |
'0' |
'42' |
'0' |
'0.3571' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.369' |
'' |
'380' |
'0' |
'1021' |
'0' |
'0.3722' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Natividad Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3436' |
'' |
'490' |
'0' |
'1425' |
'0' |
'0.3439' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Northern Inyo Hospital' |
'Q-MPH4' |
'Q-PPC-PST' |
'Prenatal and Postpartum Care: Postpartum Care (PPC-PST)' |
'Reported' |
'' |
'' |
'0.7111' |
'' |
'20' |
'0' |
'34' |
'0' |
'0.5882' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Northern Inyo Hospital' |
'Q-MPH5' |
'Q-PPC-PRE' |
'Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE)' |
'Reported' |
'' |
'' |
'0.7932' |
'' |
'18' |
'0' |
'35' |
'0' |
'0.5143' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-CAC1' |
'Q-CBP' |
'Controlling High Blood Pressure (CBP)' |
'Reported' |
'' |
'' |
'0.5474' |
'' |
'385' |
'0' |
'721' |
'0' |
'0.534' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.7637' |
'' |
'485' |
'0' |
'661' |
'0' |
'0.7337' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'392' |
'0' |
'554' |
'0' |
'0.7076' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'38' |
'0' |
'63' |
'0' |
'0.6032' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'395' |
'0' |
'2486' |
'0' |
'0.1589' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.2671' |
'' |
'834' |
'0' |
'3961' |
'0' |
'0.2106' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.7799' |
'' |
'1824' |
'0' |
'2379' |
'0' |
'0.7667' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Oak Valley Hospital District' |
'Q-PC8' |
'Q-CMS349' |
'HIV Screening Measure' |
'Reported' |
'' |
'' |
'0.3029' |
'' |
'436' |
'0' |
'1633' |
'0' |
'0.267' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-EC1' |
'Q-QPP47' |
'Advance Care Plan' |
'Reported' |
'' |
'' |
'0.4799' |
'' |
'0' |
'0' |
'270' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'' |
'1' |
'471' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.6551' |
'' |
'186' |
'0' |
'287' |
'0' |
'0.6481' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'159' |
'0' |
'585' |
'0' |
'0.2718' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC14' |
'Q-CMS138' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC14' |
'Q-CMS138' |
'Rate 1 (informational only)' |
'Reported' |
'' |
'' |
'0' |
'' |
'549' |
'0' |
'555' |
'0' |
'0.9892' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC14' |
'Q-CMS138' |
'Rate 2' |
'Reported' |
'' |
'' |
'0.812' |
'' |
'116' |
'0' |
'145' |
'0' |
'0.8' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palo Verde' |
'Q-PC14' |
'Q-CMS138' |
'Rate 3' |
'Reported' |
'' |
'' |
'0.7542' |
'' |
'116' |
'0' |
'555' |
'0' |
'0.209' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Palomar Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.7878' |
'' |
'56' |
'0' |
'72' |
'0' |
'0.7778' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.5044' |
'' |
'220' |
'0' |
'421' |
'0' |
'0.5226' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.4943' |
'' |
'246' |
'0' |
'481' |
'0' |
'0.5114' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District ' |
'Q-MPH1' |
'Q-PC02' |
'Cesarean Birth (PC02-CH)Â ' |
'Reported' |
'' |
'' |
'0.2200Â ' |
'' |
'69' |
'0' |
'370' |
'0' |
'0.1865Â ' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District ' |
'Q-MPH3' |
'Q-PC05' |
'Exclusive Breast Milk Feeding (PC-05)Â ' |
'Reported' |
'' |
'' |
'0.4776Â ' |
'' |
'332' |
'0' |
'974' |
'0' |
'0.3409Â ' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District ' |
'Q-PC1' |
'Q-BCS' |
'Breast Cancer Screening (BCS)Â ' |
'Reported' |
'' |
'' |
'0.5543Â ' |
'' |
'230' |
'0' |
'422' |
'0' |
'0.5450Â ' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District ' |
'Q-PC10' |
'Q-LSC' |
'Lead Screening in Children ' |
'Reported' |
'' |
'' |
'0.6131Â ' |
'' |
'22' |
'0' |
'148' |
'0' |
'0.1486Â ' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Pioneer Memorial Healthcare District ' |
'Q-PC9' |
'Q-IMA' |
'Immunizations for Adolescents ' |
'Reported' |
'' |
'' |
'0.3216Â ' |
'' |
'28' |
'0' |
'93' |
'0' |
'0.3011Â ' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Plumas District Hospital ' |
'Q-PC3' |
'Q-WCV' |
'Child and Adolescent Well Care Visits ' |
'Reported' |
'' |
'' |
'0.3941Â ' |
'' |
'194' |
'0' |
'699' |
'0' |
'0.2775Â ' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Plumas District Hospital ' |
'Q-PC6' |
'Q-CMS130' |
'Colorectal Cancer Screening ' |
'Reported' |
'' |
'' |
'0.4176Â ' |
'' |
'123' |
'0' |
'310' |
'0' |
'0.3968Â ' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.326' |
'' |
'60' |
'0' |
'149' |
'0' |
'0.4027' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.2298' |
'' |
'46' |
'0' |
'149' |
'0' |
'0.3087' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-BH5' |
'Q-FUI' |
'30 Days' |
'Reported' |
'' |
'' |
'0.4975' |
'' |
'32' |
'0' |
'67' |
'0' |
'0.4776' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-BH5' |
'Q-FUI' |
'7 Days' |
'Reported' |
'' |
'' |
'0.2775' |
'' |
'17' |
'0' |
'67' |
'0' |
'0.2537' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-BH5' |
'Q-FUI' |
'Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8142' |
'' |
'1251' |
'0' |
'1559' |
'0' |
'0.8024' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8026' |
'' |
'1501' |
'0' |
'1901' |
'0' |
'0.7896' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'489' |
'0' |
'544' |
'0' |
'0.8989' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-CAC5' |
'Q-CMS347' |
'Statin Therapy for the Prevention and Treatment of Cardiovascular Disease' |
'Reported' |
'' |
'' |
'0.7051' |
'' |
'4557' |
'0' |
'6601' |
'0' |
'0.6903' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4391' |
'' |
'2412' |
'0' |
'5533' |
'0' |
'0.4359' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-EC1' |
'Q-QPP47' |
'Advance Care Plan' |
'Reported' |
'' |
'' |
'0.6393' |
'' |
'2674' |
'0' |
'4397' |
'0' |
'0.6081' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 1 (informational only) -Native Hawaiian/Pacific Islander' |
'Reported' |
'' |
'' |
'0' |
'' |
'107' |
'0' |
'122' |
'0' |
'0.877' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 2 -Native Hawaiian/Pacific Islander' |
'Reported' |
'' |
'' |
'0.4738' |
'' |
'14' |
'0' |
'33' |
'0' |
'0.4242' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 3 -Native Hawaiian/Pacific Islander' |
'Reported' |
'' |
'' |
'0.7813' |
'' |
'93' |
'0' |
'122' |
'0' |
'0.7623' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-IHE1 ' |
'Q-IHE1 ' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8109' |
'' |
'987' |
'0' |
'1220' |
'0' |
'0.809' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.5067' |
'' |
'13418' |
'0' |
'27769' |
'0' |
'0.4832' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.8988' |
'' |
'33125' |
'0' |
'34614' |
'0' |
'0.957' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-PC15' |
'Q-WCC' |
'BMI' |
'Reported' |
'' |
'' |
'0.8681' |
'' |
'4360' |
'0' |
'5025' |
'0' |
'0.8677' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Nutrition' |
'Reported' |
'' |
'' |
'0.7801' |
'' |
'3895' |
'0' |
'5025' |
'0' |
'0.7751' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Physical Activity' |
'Reported' |
'' |
'' |
'0.7784' |
'' |
'3903' |
'0' |
'5025' |
'0' |
'0.7767' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Riverside University Health System' |
'Q-PC15' |
'Q-WCC' |
'Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8965' |
'' |
'396' |
'0' |
'443' |
'0' |
'0.8939' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8701' |
'' |
'1520' |
'0' |
'1758' |
'0' |
'0.8646' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.791' |
'' |
'193' |
'0' |
'247' |
'0' |
'0.7814' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-CC1' |
'Q-TRC' |
'Transitions of Care (TRC)' |
'Reported' |
'' |
'' |
'0.44' |
'' |
'102' |
'0' |
'293' |
'0' |
'0.3481' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'3910' |
'0' |
'13768' |
'0' |
'0.284' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.4784' |
'' |
'8020' |
'0' |
'17755' |
'0' |
'0.4517' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'1695' |
'0' |
'13155' |
'0' |
'0.1288' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Salinas Valley Memorial Healthcare System' |
'Q-PC7' |
'Q-DEV' |
'Developmental Screening in the First Three Years of Life' |
'Reported' |
'' |
'' |
'0.2257' |
'' |
'63' |
'0' |
'300' |
'0' |
'0.21' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'San Bernardino Mountains Community Hospital' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6847' |
'' |
'1023' |
'0' |
'1556' |
'0' |
'0.6575' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'San Bernardino Mountains Community Hospital' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5568' |
'' |
'758' |
'0' |
'1461' |
'0' |
'0.5188' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8855' |
'' |
'790' |
'0' |
'896' |
'0' |
'0.8817' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8684' |
'' |
'1615' |
'0' |
'1872' |
'0' |
'0.8627' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8775' |
'' |
'714' |
'0' |
'794' |
'0' |
'0.8992' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAD3' |
'Q-KED ' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'2267' |
'0' |
'3514' |
'0' |
'0.6451' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-IHE1' |
'Q-IHE1' |
'Breast Cancer Screening (BCS) - -Black/African American' |
'Reported' |
'' |
'' |
'0.4807' |
'' |
'395' |
'0' |
'908' |
'0' |
'0.435' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Controlling High Blood Pressure (CBP) - -Black/African American' |
'Reported' |
'' |
'' |
'0.5252' |
'' |
'658' |
'0' |
'1292' |
'0' |
'0.5093' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'182' |
'0' |
'335' |
'0' |
'0.5433' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-OA3' |
'Q-QPP415' |
'Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older' |
'Reported' |
'' |
'' |
'0.8959' |
'' |
'343' |
'0' |
'384' |
'0' |
'0.8932' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'400' |
'0' |
'474' |
'0' |
'0.8439' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-PC12' |
'Q-CMS147 ' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.7066' |
'' |
'17571' |
'0' |
'24914' |
'0' |
'0.7053' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6401' |
'' |
'11994' |
'0' |
'19616' |
'0' |
'0.6114' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'230' |
'0' |
'739' |
'0' |
'0.3112' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3619' |
'' |
'369' |
'0' |
'1013' |
'0' |
'0.3643' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Francisco General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'1005' |
'0' |
'3429' |
'0' |
'0.2931' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'San Gorgonio Memorial Hospital' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8331' |
'' |
'28' |
'0' |
'34' |
'0' |
'0.8235' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'San Gorgonio Memorial Hospital' |
'Q-OA3' |
'Q-QPP415' |
'Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older' |
'Reported' |
'' |
'' |
'0.9199' |
'' |
'82' |
'0' |
'87' |
'0' |
'0.9425' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'San Gorgonio Memorial Hospital' |
'Q-PS1' |
'Q-STK-2' |
'Discharged on Antithrombotic Therapy' |
'Reported' |
'' |
'' |
'1' |
'' |
'31' |
'0' |
'31' |
'0' |
'1' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.2878' |
'' |
'38' |
'0' |
'134' |
'0' |
'0.2836' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.1304' |
'' |
'16' |
'0' |
'134' |
'0' |
'0.1194' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.8109' |
'' |
'810' |
'0' |
'1014' |
'0' |
'0.7988' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-IHE1' |
'Q-IHE1' |
'Asthma Medication Ratio (AMR) - -White' |
'Reported' |
'' |
'' |
'0.5989' |
'' |
'42' |
'0' |
'82' |
'0' |
'0.5122' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-IHE2' |
'Q-IHE2' |
'Prenatal and Postpartum Care: Postpartum Care (PPC-PST) - -Black/African American' |
'Reported' |
'' |
'' |
'0.7111' |
'' |
'38' |
'0' |
'76' |
'0' |
'0.5' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.7133' |
'' |
'204' |
'0' |
'1067' |
'0' |
'0.1912' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'3164' |
'0' |
'14866' |
'0' |
'0.2128' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.4982' |
'' |
'9941' |
'0' |
'20982' |
'0' |
'0.4738' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'7002' |
'0' |
'18500' |
'0' |
'0.3785' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.4799' |
'' |
'107' |
'0' |
'216' |
'0' |
'0.4954' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.4828' |
'' |
'178' |
'0' |
'357' |
'0' |
'0.4986' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Joaquin General Hospital' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.4285' |
'' |
'764' |
'0' |
'1743' |
'0' |
'0.4383' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%' |
'Reported' |
'' |
'' |
'0.8589' |
'' |
'242' |
'0' |
'284' |
'0' |
'0.8521' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.9199' |
'' |
'531' |
'0' |
'555' |
'0' |
'0.9568' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8554' |
'' |
'29' |
'0' |
'34' |
'0' |
'0.8529' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-CC2' |
'Q-PCR' |
'Plan All-Cause Readmissions (PCR)' |
'Reported' |
'' |
'' |
'0' |
'' |
'12' |
'0' |
'' |
'4' |
'' |
'4' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-IHE2' |
'Q-IHE1' |
'Breast Cancer Screening (BCS) - -Black/African American' |
'Reported' |
'' |
'' |
'0.5921' |
'' |
'27' |
'0' |
'46' |
'0' |
'0.587' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 1 (informational only) -Black/African American' |
'Reported' |
'' |
'' |
'0' |
'' |
'359' |
'0' |
'363' |
'0' |
'0.989' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 2 -Black/African American' |
'Reported' |
'' |
'' |
'0.6395' |
'' |
'73' |
'0' |
'120' |
'0' |
'0.6083' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 3 -Black/African American' |
'Reported' |
'' |
'' |
'0.8688' |
'' |
'312' |
'0' |
'363' |
'0' |
'0.8595' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'50' |
'0' |
'90' |
'0' |
'0.5556' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'161' |
'0' |
'177' |
'0' |
'0.9096' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'5240' |
'0' |
'16881' |
'0' |
'0.3104' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.6514' |
'' |
'8630' |
'0' |
'13401' |
'0' |
'0.644' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'San Mateo Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6194' |
'' |
'12634' |
'0' |
'21471' |
'0' |
'0.5884' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.2436' |
'' |
'98' |
'0' |
'418' |
'0' |
'0.2344' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.1113' |
'' |
'41' |
'0' |
'418' |
'0' |
'0.0981' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-BH5' |
'Q-FUI' |
'30 Days' |
'Reported' |
'' |
'' |
'0.3979' |
'' |
'62' |
'0' |
'169' |
'0' |
'0.3669' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-BH5' |
'Q-FUI' |
'7 Days' |
'Reported' |
'' |
'' |
'0.3793' |
'' |
'62' |
'0' |
'169' |
'0' |
'0.3669' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-BH5' |
'Q-FUI' |
'Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAC5' |
'Q-CMS347' |
'Statin Therapy for the Prevention and Treatment of Cardiovascular Disease' |
'Reported' |
'' |
'' |
'0.6991' |
'' |
'4352' |
'0' |
'6366' |
'0' |
'0.6836' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'3268' |
'0' |
'6761' |
'0' |
'0.4834' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Bronchodilator' |
'Reported' |
'' |
'' |
'0.8424' |
'' |
'66' |
'0' |
'79' |
'0' |
'0.8354' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Pharmacotherapy Management of COPD Exacerbation (PCE)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Systemic Corticosteroid' |
'Reported' |
'' |
'' |
'0.6391' |
'' |
'49' |
'0' |
'79' |
'0' |
'0.6203' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Prenatal and Postpartum Care: Postpartum Care (PPC-PST) - -Black/African American' |
'Reported' |
'' |
'' |
'0.7111' |
'' |
'39' |
'0' |
'59' |
'0' |
'0.661' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Colorectal Cancer Screening - -Black/African American' |
'Reported' |
'' |
'' |
'0.5241' |
'' |
'542' |
'0' |
'1052' |
'0' |
'0.5152' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-MPH1' |
'Q-PC02' |
'Cesarean Birth (PC02-CH)' |
'Reported' |
'' |
'' |
'0.22' |
'' |
'198' |
'0' |
'974' |
'0' |
'0.2033' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'479' |
'0' |
'837' |
'0' |
'0.5723' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-OA1' |
'Q-URI ' |
'Appropriate Treatment for Upper Respiratory Infection (URI)' |
'Reported' |
'' |
'' |
'0.9434' |
'' |
'2215' |
'0' |
'2265' |
'0' |
'0.9779' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-OA2' |
'Q-AAB' |
'Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB)' |
'Reported' |
'' |
'' |
'0.7039' |
'' |
'64' |
'0' |
'81' |
'0' |
'0.7901' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.5184' |
'' |
'24209' |
'0' |
'48785' |
'0' |
'0.4962' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'10773' |
'0' |
'27343' |
'0' |
'0.394' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3591' |
'' |
'151' |
'0' |
'418' |
'0' |
'0.3612' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.4139' |
'' |
'1195' |
'0' |
'2832' |
'0' |
'0.422' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Santa Clara Valley Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3424' |
'' |
'2297' |
'0' |
'6705' |
'0' |
'0.3426' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Seneca Healthcare District' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'0' |
'0' |
'228' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Sierra View District Hospital' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.2671' |
'' |
'257' |
'0' |
'4570' |
'0' |
'0.0562' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Sonoma Valley Hospital ' |
'Q-PS4' |
'Q-CDI' |
'Reduction in Hospital Acquired Clostridium Difficile Infections ' |
'Reported' |
'' |
'' |
'0Â ' |
'' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Sonoma Valley Hospital ' |
'Q-PS5' |
'Q-SSI' |
'Surgical Site Infection (SSI)Â ' |
'Reported' |
'' |
'' |
'0Â ' |
'' |
'0' |
'0' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Southern Inyo Hospital' |
'Q-PC1' |
'Q-BCS' |
'Breast Cancer Screening (BCS)' |
'' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Southern Inyo Hospital' |
'Q-PC3' |
'Q-WCV' |
'Child and Adolescent Well Care Visits' |
'' |
'' |
'' |
'0.5433' |
'' |
'100' |
'0' |
'187' |
'0' |
'0.5348' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Surprise Valley ' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'0' |
'0' |
'30' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.3058' |
'' |
'17' |
'0' |
'56' |
'0' |
'0.3036' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.2159' |
'' |
'12' |
'0' |
'56' |
'0' |
'0.2143' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-CC1' |
'Q-TRC' |
'Transitions of Care (TRC)' |
'Reported' |
'' |
'' |
'0.5897' |
'' |
'58' |
'0' |
'102' |
'0' |
'0.5686' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-PC1' |
'Q-BCS' |
'Breast Cancer Screening (BCS)' |
'Reported' |
'' |
'' |
'0.622' |
'' |
'80' |
'0' |
'129' |
'0' |
'0.6202' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'664' |
'0' |
'1583' |
'0' |
'0.4195' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-PC9' |
'Q-IMA' |
'Immunizations for Adolescents' |
'Reported' |
'' |
'' |
'0.309' |
'' |
'22' |
'0' |
'89' |
'0' |
'0.2472' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-PS4' |
'Q-CDI' |
'Reduction in Hospital Acquired Clostridium Difficile Infections' |
'Reported' |
'' |
'' |
'0' |
'' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'' |
'1' |
'30' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Tahoe Forest Hospital District' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'12' |
'0' |
'55' |
'0' |
'0.2182' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-BH1' |
'Q-COB' |
'Concurrent Use of Opioids and Benzodiazepines (COB-AD)' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-BH4' |
'Q-OHD' |
'Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD)' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-BH5' |
'Q-FUI' |
'30 Days' |
'Reported' |
'' |
'' |
'0.3894' |
'' |
'' |
'1' |
'124' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-BH5' |
'Q-FUI' |
'7 Days' |
'Reported' |
'' |
'' |
'0.234' |
'' |
'' |
'1' |
'124' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-BH5' |
'Q-FUI' |
'Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-BH6' |
'Q-POD' |
'Pharmacotherapy for Opioid Use Disorder*' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-EC1' |
'Q-QPP47' |
'Advance Care Plan' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.1696' |
'' |
'' |
'1' |
'533' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.7182' |
'' |
'2129' |
'0' |
'2414' |
'0' |
'0.8819' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'252' |
'0' |
'11730' |
'0' |
'0.0215' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-PC14' |
'Q-CMS138' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-PC14' |
'Q-CMS138' |
'Rate 1 (informational only)' |
'Reported' |
'' |
'' |
'0' |
'' |
'3363' |
'0' |
'3544' |
'0' |
'0.9489' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-PC14' |
'Q-CMS138' |
'Rate 2' |
'Reported' |
'' |
'' |
'0.1093' |
'' |
'24' |
'0' |
'1251' |
'0' |
'0.0192' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Tri-City Medical Center' |
'Q-PC14' |
'Q-CMS138' |
'Rate 3' |
'Reported' |
'' |
'' |
'0.7542' |
'' |
'24' |
'0' |
'3544' |
'0' |
'0.0068' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Trinity Hospital ' |
'Q-PC3' |
'Q-WCV' |
'Child and Adolescent Well Care Visits ' |
'Reported' |
'' |
'' |
'0.3941Â ' |
'' |
'185' |
'0' |
'614' |
'0' |
'0.3013Â ' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8249' |
'' |
'763' |
'0' |
'937' |
'0' |
'0.8143' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-CC2' |
'Q-PCR' |
'Plan All-Cause Readmissions (PCR)' |
'Reported' |
'' |
'' |
'0' |
'' |
'15' |
'0' |
'' |
'4' |
'' |
'4' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Controlling High Blood Pressure (CBP) - -Black/African American' |
'Reported' |
'' |
'' |
'0.586' |
'' |
'30' |
'0' |
'52' |
'0' |
'0.5769' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Exclusive Breast Milk Feeding (PC-05) - -Black/African American' |
'Reported' |
'' |
'' |
'0.4776' |
'' |
'32' |
'0' |
'75' |
'0' |
'0.4267' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'28' |
'0' |
'51' |
'0' |
'0.549' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'76' |
'0' |
'90' |
'0' |
'0.8444' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5079' |
'' |
'2139' |
'0' |
'4605' |
'0' |
'0.4645' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-PS1' |
'Q-STK-2' |
'Discharged on Antithrombotic Therapy' |
'Reported' |
'' |
'' |
'0.9918' |
'' |
'309' |
'0' |
'332' |
'0' |
'0.9307' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3886' |
'' |
'26' |
'0' |
'66' |
'0' |
'0.3939' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3941' |
'' |
'30' |
'0' |
'75' |
'0' |
'0.4' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Davis Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'94' |
'0' |
'283' |
'0' |
'0.3322' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.1539' |
'' |
'12' |
'0' |
'89' |
'0' |
'0.1348' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.0938' |
'' |
'' |
'1' |
'89' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8364' |
'' |
'914' |
'0' |
'1105' |
'0' |
'0.8271' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.854' |
'' |
'1745' |
'0' |
'2061' |
'0' |
'0.8467' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8408' |
'' |
'415' |
'0' |
'496' |
'0' |
'0.8367' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAC5' |
'Q-CMS347' |
'Statin Therapy for the Prevention and Treatment of Cardiovascular Disease' |
'Reported' |
'' |
'' |
'0.7357' |
'' |
'1261' |
'0' |
'1741' |
'0' |
'0.7243' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'783' |
'0' |
'1293' |
'0' |
'0.6056' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CC2' |
'Q-PCR' |
'Plan All-Cause Readmissions (PCR)' |
'Reported' |
'' |
'' |
'0' |
'' |
'34' |
'0' |
'41.0588' |
'0' |
'0.8281' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-MPH6' |
'Q-PRS-E' |
'Prenatal Immunization Status' |
'Reported' |
'' |
'' |
'0.4576' |
'' |
'195' |
'0' |
'401' |
'0' |
'0.4863' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'465' |
'0' |
'498' |
'0' |
'0.9337' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.4955' |
'' |
'5945' |
'0' |
'13478' |
'0' |
'0.4411' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5916' |
'' |
'7787' |
'0' |
'13967' |
'0' |
'0.5575' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-PS1' |
'Q-STK-2' |
'Discharged on Antithrombotic Therapy' |
'Reported' |
'' |
'' |
'0.9918' |
'' |
'395' |
'0' |
'422' |
'0' |
'0.936' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-PS5' |
'Q-SSI' |
'Surgical Site Infection (SSI)' |
'Reported' |
'' |
'' |
'0' |
'' |
'33' |
'0' |
'38.08' |
'0' |
'0.8666' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'' |
'1' |
'38' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'338' |
'0' |
'1051' |
'0' |
'0.3216' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Irvine Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'448' |
'0' |
'1400' |
'0' |
'0.32' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Los Angeles Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.816' |
'' |
'1259' |
'0' |
'1565' |
'0' |
'0.8045' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Los Angeles Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.6969' |
'' |
'130' |
'0' |
'220' |
'0' |
'0.5909' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Los Angeles Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'22' |
'0' |
'46' |
'0' |
'0.4783' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC Los Angeles Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC Los Angeles Medical Center' |
'Q-IHE2' |
'Q-IHE1' |
'Colorectal Cancer Screening - -Native Hawaiian/Pacific Islander' |
'Reported' |
'' |
'' |
'0.3059' |
'' |
'' |
'1' |
'33' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC Los Angeles Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5004' |
'' |
'5355' |
'0' |
'27828' |
'0' |
'0.1924' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH1' |
'Q-COB' |
'Concurrent Use of Opioids and Benzodiazepines (COB-AD)' |
'Reported' |
'' |
'' |
'0.1415' |
'' |
'21' |
'0' |
'109' |
'0' |
'0.1927' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Remission (Adolescents) - informational only' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Response (Adolescents) - informational only' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Follow-Up PHQ-9 (Adolescents) - informational only' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'0' |
'0' |
'0' |
'0' |
'0' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Remission (Adults)' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Response (Adults)' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Follow-Up PHQ-9 (Adults)' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH2' |
'Q-DRR-E' |
'Depression Remission or Response for Adolescents and Adults (DRR-E)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH4' |
'Q-OHD' |
'Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD)' |
'Reported' |
'' |
'' |
'0.0397' |
'' |
'' |
'1' |
'95' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-BH6' |
'Q-POD' |
'Pharmacotherapy for Opioid Use Disorder*' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8095' |
'' |
'951' |
'0' |
'1193' |
'0' |
'0.7972' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.85' |
'' |
'2365' |
'0' |
'2808' |
'0' |
'0.8422' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.7772' |
'' |
'920' |
'0' |
'1201' |
'0' |
'0.766' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'103' |
'0' |
'179' |
'0' |
'0.5754' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Bronchodilator' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Pharmacotherapy Management of COPD Exacerbation (PCE)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Systemic Corticosteroid' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CC2' |
'Q-PCR' |
'Plan All-Cause Readmissions (PCR)' |
'Reported' |
'' |
'' |
'0' |
'' |
'' |
'1' |
'' |
'1' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Child and Adolescent Well Care Visits - -Black/African American' |
'Reported' |
'' |
'' |
'0.3941' |
'' |
'13' |
'0' |
'36' |
'0' |
'0.3611' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'HIV Viral Suppression (HVL-AD) - -Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.776' |
'' |
'30' |
'0' |
'39' |
'0' |
'0.7692' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-PC10' |
'Q-LSC' |
'Lead Screening in Children' |
'Reported' |
'' |
'' |
'0.6131' |
'' |
'94' |
'0' |
'164' |
'0' |
'0.5732' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.5052' |
'' |
'1421' |
'0' |
'3102' |
'0' |
'0.4581' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6869' |
'' |
'1527' |
'0' |
'2302' |
'0' |
'0.6633' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'' |
'1' |
'38' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Diego Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'40' |
'0' |
'174' |
'0' |
'0.2299' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-BH1' |
'Q-COB' |
'Concurrent Use of Opioids and Benzodiazepines (COB-AD)' |
'Reported' |
'' |
'' |
'0.1411' |
'' |
'51' |
'0' |
'346' |
'0' |
'0.1474' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.2057' |
'' |
'' |
'1' |
'52' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.0749' |
'' |
'' |
'1' |
'52' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8313' |
'' |
'874' |
'0' |
'1064' |
'0' |
'0.8214' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8572' |
'' |
'554' |
'0' |
'648' |
'0' |
'0.8549' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'494' |
'0' |
'818' |
'0' |
'0.6039' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Bronchodilator' |
'Reported' |
'' |
'' |
'0.9057' |
'' |
'39' |
'0' |
'43' |
'0' |
'0.907' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Pharmacotherapy Management of COPD Exacerbation (PCE)' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-CAR2' |
'Q-PCE' |
'Systemic Corticosteroid' |
'Reported' |
'' |
'' |
'0.636' |
'' |
'25' |
'0' |
'43' |
'0' |
'0.5814' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-IHE2' |
'Q-IHE1' |
'Controlling High Blood Pressure (CBP) - -Black/African American' |
'Reported' |
'' |
'' |
'0.5601' |
'' |
'131' |
'0' |
'239' |
'0' |
'0.5481' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8216' |
'' |
'362' |
'0' |
'441' |
'0' |
'0.8209' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC10' |
'Q-LSC' |
'Lead Screening in Children' |
'Reported' |
'' |
'' |
'0.6131' |
'' |
'118' |
'0' |
'258' |
'0' |
'0.4574' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.6462' |
'' |
'20067' |
'0' |
'31444' |
'0' |
'0.6382' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6049' |
'' |
'4033' |
'0' |
'7048' |
'0' |
'0.5722' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC15' |
'Q-WCC' |
'BMI' |
'Reported' |
'' |
'' |
'0.8718' |
'' |
'2342' |
'0' |
'2585' |
'0' |
'0.906' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Nutrition' |
'Reported' |
'' |
'' |
'0.6409' |
'' |
'1604' |
'0' |
'2585' |
'0' |
'0.6205' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Counseling for Physical Activity' |
'Reported' |
'' |
'' |
'0.6249' |
'' |
'1567' |
'0' |
'2585' |
'0' |
'0.6062' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center' |
'Q-PC15' |
'Q-WCC' |
'Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center ' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center ' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'51' |
'0' |
'173' |
'0' |
'0.2948' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center ' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'32' |
'0' |
'113' |
'0' |
'0.2832' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'UC San Francisco Medical Center ' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'202' |
'0' |
'816' |
'0' |
'0.2475' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-BH1' |
'Q-COB' |
'Concurrent Use of Opioids and Benzodiazepines (COB-AD)' |
'Reported' |
'' |
'' |
'0.1187' |
'' |
'127' |
'0' |
'1037' |
'0' |
'0.1225' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-BH3' |
'Q-FUA' |
'30 Days' |
'Reported' |
'' |
'' |
'0.214' |
'' |
'52' |
'0' |
'258' |
'0' |
'0.2016' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-BH3' |
'Q-FUA' |
'7 Days' |
'Reported' |
'' |
'' |
'0.1172' |
'' |
'27' |
'0' |
'258' |
'0' |
'0.1047' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-BH3' |
'Q-FUA' |
'Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-BH4' |
'Q-OHD' |
'Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD)' |
'Reported' |
'' |
'' |
'0.0337' |
'' |
'30' |
'0' |
'870' |
'0' |
'0.0345' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAC2' |
'Q-QPP118' |
'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%%)' |
'Reported' |
'' |
'' |
'0.8353' |
'' |
'370' |
'0' |
'448' |
'0' |
'0.8259' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.9199' |
'' |
'815' |
'0' |
'879' |
'0' |
'0.9272' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAC4' |
'Q-CMS135' |
'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)' |
'Reported' |
'' |
'' |
'0.8406' |
'' |
'220' |
'0' |
'263' |
'0' |
'0.8365' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'1643' |
'0' |
'3131' |
'0' |
'0.5248' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-IHE1' |
'Q-IHE1' |
'Improving Health Equity 1Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-IHE2' |
'Q-IHE1' |
'Chlamydia Screening in Women (CHL) - -American Indian/Alaskan Native' |
'Reported' |
'' |
'' |
'0.4829' |
'' |
'43' |
'0' |
'100' |
'0' |
'0.43' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Preventive Care and Screening: Influenza Immunization - -Black/African American' |
'Reported' |
'' |
'' |
'0.478' |
'' |
'292' |
'0' |
'647' |
'0' |
'0.4513' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-IHE2' |
'Q-IHE2' |
'Improving Health Equity 2Â Unlock Metric' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-OA4' |
'Q-LBP' |
'Use of Imaging Studies for Low Back Pain (LBP)' |
'Reported' |
'' |
'' |
'0.8282' |
'' |
'844' |
'0' |
'953' |
'0' |
'0.8856' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-PC11' |
'Q-CMS69' |
'Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6661' |
'' |
'16389' |
'0' |
'25732' |
'0' |
'0.6369' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.606' |
'' |
'18283' |
'0' |
'30807' |
'0' |
'0.5935' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-PC13' |
'Q-CMS2' |
'Preventive Care and Screening: Screening for Depression and Follow-Up Plan' |
'Reported' |
'' |
'' |
'0.6511' |
'' |
'19098' |
'0' |
'30626' |
'0' |
'0.6236' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'0.377' |
'' |
'24' |
'0' |
'63' |
'0' |
'0.381' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3643' |
'' |
'695' |
'0' |
'1894' |
'0' |
'0.3669' |
'0' |
'N/A' |
'PY4' |
'DPH' |
'Ventura County Medical Center' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3552' |
'' |
'1103' |
'0' |
'3091' |
'0' |
'0.3568' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-CAC3' |
'Q-QPP6' |
'Coronary Artery Disease (CAD): Antiplatelet Therapy' |
'Reported' |
'' |
'' |
'0.9199' |
'' |
'176' |
'0' |
'186' |
'0' |
'0.9462' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-CAC5' |
'Q-CMS347' |
'Statin Therapy for the Prevention and Treatment of Cardiovascular Disease' |
'Reported' |
'' |
'' |
'0.6892' |
'' |
'189' |
'0' |
'281' |
'0' |
'0.6726' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-CAD3' |
'Q-KED' |
'Kidney Health Evaluation for Patients with Diabetes' |
'Reported' |
'' |
'' |
'0.4676' |
'' |
'102' |
'0' |
'182' |
'0' |
'0.5604' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-PC12' |
'Q-CMS147' |
'Preventive Care and Screening: Influenza Immunization' |
'Reported' |
'' |
'' |
'0.476' |
'' |
'1527' |
'0' |
'3400' |
'0' |
'0.4491' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-PC14' |
'Q-CMS138' |
'Rate 1 (informational only)' |
'Reported' |
'' |
'' |
'0' |
'' |
'3755' |
'0' |
'3849' |
'0' |
'0.9756' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-PC14' |
'Q-CMS138' |
'Rate 2' |
'Reported' |
'' |
'' |
'0.2879' |
'' |
'64' |
'0' |
'294' |
'0' |
'0.2177' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-PC14' |
'Q-CMS138' |
'Rate 3' |
'Reported' |
'' |
'' |
'0.9195' |
'' |
'3525' |
'0' |
'3849' |
'0' |
'0.9158' |
'0' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System' |
'Q-PC14' |
'Q-CMS138' |
'Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'0' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System ' |
'Q-CAD1' |
'Q-HBD' |
'Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%%) (CDC-H9)*' |
'Reported' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System ' |
'Q-CAD1' |
'Q-HBD' |
'Black/African-American' |
'Reported' |
'' |
'' |
'N/A' |
'3' |
'' |
'1' |
'' |
'4' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System ' |
'Q-CAD1' |
'Q-HBD' |
'Hispanic/Latino' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'' |
'1' |
'30' |
'0' |
'' |
'1' |
'N/A' |
'PY4' |
'DMPH' |
'Washington Hospital Healthcare System ' |
'Q-CAD1' |
'Q-HBD' |
'Total Population' |
'Reported' |
'' |
'' |
'0.3406' |
'' |
'35' |
'0' |
'165' |
'0' |
'0.2121' |
'0' |
'N/A' |